IMAC Deferred Long Term Liab from 2010 to 2024

BACK Stock  USD 1.22  0.03  2.40%   
IMAC Holdings Deferred Long Term Liabilities yearly trend continues to be quite stable with very little volatility. The value of Deferred Long Term Liabilities is projected to decrease to about 198.6 K. Deferred Long Term Liabilities is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. View All Fundamentals
 
Deferred Long Term Liabilities  
First Reported
2010-12-31
Previous Quarter
219.4 K
Current Value
198.6 K
Quarterly Volatility
61.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check IMAC Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IMAC Holdings' main balance sheet or income statement drivers, such as Depreciation And Amortization of 383.4 K, Interest Expense of 94.1 K or Selling And Marketing Expenses of 7.3 K, as well as many indicators such as Price To Sales Ratio of 0.45, Dividend Yield of 0.0 or Days Sales Outstanding of 56.09. IMAC financial statements analysis is a perfect complement when working with IMAC Holdings Valuation or Volatility modules.
  
Check out the analysis of IMAC Holdings Correlation against competitors.
For more information on how to buy IMAC Stock please use our How to buy in IMAC Stock guide.

Latest IMAC Holdings' Deferred Long Term Liab Growth Pattern

Below is the plot of the Deferred Long Term Liab of IMAC Holdings over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. IMAC Holdings' Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IMAC Holdings' overall financial position and show how it may be relating to other accounts over time.
Deferred Long Term Liab10 Years Trend
Slightly volatile
   Deferred Long Term Liab   
       Timeline  

IMAC Deferred Long Term Liab Regression Statistics

Arithmetic Mean289,159
Geometric Mean282,284
Coefficient Of Variation21.19
Mean Deviation55,391
Median335,318
Standard Deviation61,274
Sample Variance3.8B
Range165K
R-Value(0.80)
Mean Square Error1.4B
R-Squared0.65
Significance0.0003
Slope(11,005)
Total Sum of Squares52.6B

IMAC Deferred Long Term Liab History

2024198.6 K
2023219.4 K
2020243.8 K
2019170.3 K

About IMAC Holdings Financial Statements

IMAC Holdings investors utilize fundamental indicators, such as Deferred Long Term Liab, to predict how IMAC Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Deferred Long Term Liabilities219.4 K198.6 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether IMAC Holdings is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if IMAC Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Imac Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Imac Holdings Stock:
Check out the analysis of IMAC Holdings Correlation against competitors.
For more information on how to buy IMAC Stock please use our How to buy in IMAC Stock guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IMAC Holdings. If investors know IMAC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IMAC Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.03)
Revenue Per Share
7.719
Quarterly Revenue Growth
(0.59)
Return On Assets
(0.38)
Return On Equity
(3.32)
The market value of IMAC Holdings is measured differently than its book value, which is the value of IMAC that is recorded on the company's balance sheet. Investors also form their own opinion of IMAC Holdings' value that differs from its market value or its book value, called intrinsic value, which is IMAC Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IMAC Holdings' market value can be influenced by many factors that don't directly affect IMAC Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IMAC Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if IMAC Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IMAC Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.